Paul W O'Connor

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects

Jiwon Oh, Jiwon Oh, P. O'Connor, 2014, Therapeutic advances in neurological disorders.

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

Ludwig Kappos, Jan Hillert, Gilles Edan, 2007, The Lancet Neurology.

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Ludwig Kappos, Deborah Bauer, Jerry S Wolinsky, 2014, The Lancet Neurology.

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Ludwig Kappos, Gavin Giovannoni, Frances Lynn, 2006, The New England journal of medicine.